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Objectives: The purpose of this retrospective cohort study was to investigate the relationship between exposure of Korean work-
ers to petrochemicals in the refi nery/petrochemical industry and lymphohematopoietic cancers.
Methods: The cohort consisted of 8,866 male workers who had worked from the 1960s to 2007 at one refi nery and six petro-
chemical companies located in a refi nery/petrochemical complex in Korea that produce benzene or use benzene as a raw mate-
rial. Standardized mortality ratios (SMRs) and standardized incidence ratios (SIRs) were calculated for 1992-2007 and 1997-2005 
based on the death rate and cancer incidence rate of the Korean male population according to job title (production, maintenance, 
laboratory, and offi ce workers). 
Results: The overall mortality and most cause-specifi c mortalities were lower among these workers than those of the general 
Korean population. Increased SMRs were observed for leukemia (4/1.45; SMR 2.77, 95% CI: 0.75-7.09) and lymphohematopoietic 
cancers (5/2.51; SMR 2, 95% CI: 0.65-4.66) in production workers, and increased SIRs were also observed in leukemia (3/1.34; SIR 
2.24, 95% CI: 0.46-6.54) and lymphohematopoietic cancers (5/3.39; SIR 1.47, 95% CI: 0.48-3.44) in production workers, but the re-
sults were not statistically signifi cant. 
Conclusion: The results showed a potential relationship between leukemia and lymphohematopoietic cancers and exposure to 
benzene in refi nery/petrochemical complex workers. This study yielded limited results due to a short observational period; there-
fore, a follow-up study must be performed to elucidate the relationship between petrochemical exposure and cancer rates.
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Introduction
The refinery/petrochemical industry is indispensable because 
it produces fuels, plastic resins, rubber, and various chemicals 
including agricultural chemicals. However, employees working 
in the refinery/petrochemical industry are exposed to many 
hazardous chemicals. Among them, benzene, 1,3-butadiene, 
and ethylene oxide are representative carcinogens.
Many studies have been conducted to determine the re-
lationship between exposure in the refinery/petrochemical in-
dustry and the increasing risk of cancer [1-9]. But no published 
report has been conducted on the cancer risk of Korean work-
ers working in the refinery/petrochemical industry.
The refining industry began in the 1960s, and the full-scale 
petrochemical industry started in the 1970s in Korea. The refin-
ery/petrochemical industry began first in Ulsan city, and other 
complexes were built in Yosu and Daesan. This retrospective 
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cohort comprised 8,866 male workers who worked at a refin-
ery/petrochemical complex where benzene was manufactured 
or used as a raw material. 
We investigated the relationship between benzene expo-
sure and lymphohematopoietic cancer mortality and morbidity 
in refinery/petrochemical industry workers.
Materials and Methods 
Study population 
The study population consisted of male workers in a refinery 
and petrochemical complex composed of  one refinery and 
six large petrochemical factories. Among these, four factories 
and the refinery produce benzene, three factories had naph-
tha cracking centers, and two factories used benzene as a raw 
material to make other chemical products. Employee data for 
the seven factories, including resident registration numbers (a 
unique Korean identification number), date of  employment 
and retirement, and departments were collected from the date 
of business initiation (the early 1960s) to Dec 31, 2007. Female 
workers were excluded from the study population. In total, 
8,866 male workers with a work history of one or more days 
in the refinery/petrochemical complex were included in this 
study.
The most recent departments of the employees were used 
to categorize the workers into four groups: production, main-
tenance, laboratory, or office workers. The employees were 
also divided into manufacturing and office worker groups. The 
manufacturing workers included those employed in the pro-
cessing operation (production), maintenance, and laboratory 
departments. The office workers included those in the sales 
department and the general office. 
Cancer mortality and morbidity data 
Mortality data are readily accessible in Korea, given the resi-
dent registration numbers, and the data were attained from the 
Korea National Statistical Office (KNSO). Data on mortality 
and causes of  death were obtained for 16 years from Jan 1, 
1992 to Dec 31, 2007. Causes of death were coded using the 
10th Revision of  the International Classification of  Diseases. 
The cancer classification was in accordance with the KNSO 
classification (Korea Classification of Diseases and Causes of 
Death, 4th edition).
Cancer incidence was identified using the Central Regis-
try of Cancer in Korea. Morbidity of the subjects was observed 
retrospectively for a 9-year period from Jan 1, 1997 to Dec 31, 
2005. 
Data analysis 
The observation period for cancer mortality of  the subjects 
was 16 years from Jan 1, 1992 to Dec 31, 2007. The 16-year 
observation period was divided into four calendar periods; 
1992-1996, 1997-2001, 2002-2006, and 2007. National popula-
tion data for 1994, 1999, 2005, and 2007 with 5-year age group 
intervals of those aged 20-80 years were used as the reference 
population.
For workers who were employed before Jan.1, 1992, and 
who died during the observation period, the number of person 
years was calculated from Jan 1, 1992 to the date of death. Sub-
jects who survived throughout the study period were observed 
until the final date of this study, Dec 31, 2007. If  workers were 
hired during the observational period, their person years were 
considered from the date of hire to the date of death or Dec 31, 
2007. Workers who retired before the beginning of the observa-
tion period, Jan 1, 1992, were excluded from the study, as their 
mortality before 1992 could not be determined. 
Standardized mortality ratios (SMRs) of  all-cause mor-
tality, overall cancer mortality, lymphohematopoietic cancer 
mortality, and other cancer mortalities were calculated after 
dividing the subjects into production, maintenance, laboratory 
Table 1. General characteristics of study subjects
Variable No. %
Age of employment 20-24 1,247 14.06
25-29 3,941 44.45
30-34 1,568 17.69
35-39     937 10.57
40-44     643   7.25
45-49     293   3.30
50-54     174   1.96
55-59       52   0.59  
60-64         6   0.07
65-69        4   0.05
70-74        1   0.01
Job Product 4,194 47.30
Maintenance 1,451 16.37
Laboratory 1,099 12.40
Office 2,122 23.93
Total 8,866    100
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and office workers, and into manufacturing and office workers. 
The expected numbers were calculated from age-specific na-
tional mortality rates for the 5-year age groups and 4 calendar 
periods. 
Cancer morbidity was observed from Jan 1, 1997 to Dec 
31, 2005. The standard population age groups with 5-year in-
tervals who were aged 20-80 years of age in 2003 were used as 
the reference population. Standardized incidence rations (SIRs) 
were calculated, after calculating the expected numbers from 
age-specific cancer incidence rates for the 5-year age groups in 
2003.
A SAS macro program was used to tabulate the number 
of case and person-years [10]. After indirect age standardiza-
tion, SMRs, SIRs, and exact Poisson confidence intervals (CIs) 
were computed using another SAS macro program [11]. 
Results
General characteristics of subjects 
Subjects aged 20-29 years at the time of  employment were 
58.51% of all subjects. The largest proportion among the four 
job categories was production, with 47.3%. Manufacturing 
jobs, including production, maintenance, and laboratory jobs, 
were 76.07% of all jobs (Table 1).
SMRs for all workers and by manufacturing/office 
job 
SMRs of all-cause mortality and overall cancer mortality were 
calculated after dividing the subjects into manufacturing and 
office workers (Table 2). Although the SMRs of the two groups 
were significantly lower when compared with those of the gen-
eral population, SMRs for leukemia (2.12; 95% CI: 0.69-4.96) 
and lymphohematopoietic cancers (1.72; 95% CI: 0.69-3.54) 
tended to be higher in manufacturing workers, compared with 
Table 2. Mortality results for all workers and by manufacturing/office job
Cause of death
All workers (PY = 116322) Manufacturing (PY = 88357) Office (PY = 27966)
Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
All causes 159 0.42 0.36-0.49 120 0.44 0.36-0.53 39 0.36 0.26-0.50
All cancer   45 0.49 0.36-0.66 34 0.54 0.37-0.75 11 0.40 0.20-0.71
Oral cavity, pharynx 2 1.25 0.15-4.5 1 0.89 0.02-4.98 1 2.05 0.05-11.43
Esophagus 0 -        0-1.34 0 -     0-2.02 0 -     0-4.01
Stomach 4 0.24 0.06-0.6 3 0.25 0.05-0.74 1 0.2     0-1.09
Colon, anus 5 0.86       0.28-2 2 0.49 0.06-1.78 3 1.71 0.35-4.99
Liver, biliary   15 0.51   0.29-0.85 13 0.64 0.34-1.09 2 0.23 0.03-0.82
Pancreas 4 1.11   0.30-2.83 3 1.21 0.25-3.52 1 0.89 0.02-4.94
Larynx 0 -        0-3.61 0 -     0-5.44 0 -      0-4.94 
Lung 5 0.35   0.11-0.83 3 0.31 0.06-0.91 2 0.44 0.05-1.59
Skin 0 -          0-16.19 0 -        0-22.99 0 -        0-54.75
Prostate 0 -        0-8.16 0 -        0-12.24 0 -        0-24.53
Bladder 0 -        0-4.78 0 -      0-7.01 0 -        0-15.04
Neurologic 0 -        0-1.55 0 -      0-2.14 0 -      0-5.64
Lymphohematopoietic 8 1.43   0.62-2.82 7 1.72 0.69-3.54 1 0.66 0.02-3.66
Non-Hodgkins's lymphoma 3 1.54   0.32-4.50 2 1.43 0.17-5.16 1 1.82 0.05-10.15
Multiple myeloma 0 -        0-6.45 0 -      0-9.40 0 -      0-20.51
Leukemia 5 1.57 0.51-3.67 5 2.12 0.69-4.96 0 -    0-3.63
PY: person-year, Obs: observed number, SMR: standardized mortality ratio, CI: confidence interval.
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the general population. However the result was not significant.
 
SMRs according to the four job classifications
After dividing subjects into production, maintenance, labora-
tory, and office workers, the SMRs for all-cause mortality, 
overall cancer mortality, and specific cancer mortalities were 
calculated. The SMRs for leukemia and lymphohematopoietic 
cancers were 2.77 (95% CI: 0.75-7.09) and 2 (95% CI: 0.65-
4.66), respectively, in production workers. (Table 3). 
SIRs for all workers and by manufacturing/office job 
SIRs for all overall cancer mortality and specific cancer mortal-
ities were calculated after dividing subjects into manufacturing 
and office workers (Table 4). The SIR for leukemia (1.40; 95% 
CI: 0.29-4.08) increased in manufacturing workers, whereas the 
SIRs for non-Hodgkin's lymphoma (0.70; 95% CI: 0.08-2.52) 
and lymphohematopoietic cancers (0.92; 95% CI: 0.30-2.14) 
were lower than those in the general population. 
SIRs according to the four job classifications 
SIRs for lymphohematopoietic cancers among production, 
maintenance, laboratory, and office workers were calculated 
(Table 5). The SIRs showed no significantly elevated risks for 
leukemia (2.24; 95% CI: 0.46-6.54) and lymphohematopoietic 
cancers (1.47; 95% CI: 0.48-3.44). The risk of non-Hodgkin’s 
lymphoma among production workers (0.56; 95% CI: 0.07-
2.03) appeared to be lower than that of  the general Korean 
male population. 
Discussion 
   
According to the International Agency for Research on Cancer, 
the following are listed as carcinogens to humans (group 1) 
that cause lymphohematopoietic cancer. Benzene (acute non-
lymphocytic leukemia and multiple myeloma), 1,3-butadiene 
(leukemia and lymphoma), ethylene oxide (leukemia), ionizing 
radiation (leukemia), the manufacture and repair of  shoes/
Table 3. Mortality results by four job classification
Cause of death
Product (PY = 54187) Maintenance (PY = 20596) Laboratory (PY = 13571) Office (PY = 27966)
Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI Obs SMR 95% CI
All causes 84 0.50 0.40-0.62 29 0.41 0.28-0.59 7 0.20 0.08-0.41 39 0.36 0.26-0.50
All cancer 23 0.58 0.37-0.88 8 0.47 0.20-0.94 3 0.41 0.08-1.20 11 0.40 0.20-0.71
Oral cavity, pharynx   0 - 0-4.34 1 3.36 0.09-18.7 0 - 0-22.86 1 2.05 0.05-11.40
Esophagus   0 - 0-3.19 0 - 0-7.38 0 - 0-21.55 0 - 0-4.01
Stomach   1 0.14 0-0.76 1 0.32 0.01-1.79 1 0.74 0.02-4.10 1 0.20 0-1.09
Colon, anus  2 0.79 0.1-2.87 0 - 0-2.80 0 - 0-6.27 3 1.71 0.35-4.99
Liver, biliary 11 0.88 0.44-1.58 2 0.36 0.04-1.31 0 - 0-1.25 2 0.23 0.03-0.82
Pancreas   0 - 0-1.94 2 2.99 0.36-10.8 1 3.63   0.09-20.24 1 0.89 0.02-4.94
Larynx   0 - 0-8.48 0 - 0-20.1 0 -   0-61.14 0 - 0-10.70
Lung   2 0.33 0.04-1.19 0 - 0-1.17 1 1.03 0.03-5.73 2 0.44 0.05-1.59
Skin   0 - 0-37.89 0 - 0-84.30 0 - 0-191.22 0 - 0-54.80
Prostate   0 - 0-18.19 0 -   0-49 0 - 0-114.12 0 - 0-24.50
Bladder   0 -  0-11 0 - 0-26.70 0 - 0-70.50 0 -  0-15
Neurologic   0 - 0-3.48 0 - 0-8.52 0 - 0-15.92 0 - 0-5.64
Lymphohematopoietic   5    2 0.65-4.66 2 1.96 0.24-7.08 0 - 0-5.45 1 0.66 0.02-3.66
Non-Hodgkins's 
lymphoma
  1 1.16 0.03-6.46 1 2.8 0.07-15.60 0 - 0-16.48 1 1.82 0.05-10.20
Multiple myeloma   0 - 0-15.21 0 - 0-34.60 0 - 0-85.67 0 - 0-20.50
Leukemia   4 2.77 0.75-7.09 1 1.73 0.04-9.66 0 - 0-9 0 - 0-3.63
PY: person-year, Obs: observed number, SMR: standardized mortality ratio, CI: confidence interval.
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boot (leukemia), and the rubber industry (leukemia and lym-
phoma) for the use of benzene. Additionally, trichloroethylene 
(lymphoma) is classified as group 2A, probable carcinogens to 
humans, and chlorophenols and phenoxyacetic acid herbicides 
(lymphoma), gasoline (leukemia), hexachlorocyclohexane (leu-
kemia), and 2,3,7,8-tetrachlorodibenzo-p-dioxin (lymphoma) 
are group 2B, possible carcinogens to humans [12]. Among 
these, benzene and 1,3-butadiene are largely used in the refinery 
and petrochemical industry, and might be exemplary carcino-
gens, causing lymphohematopoietic cancers in the refinery/
petrochemical industry. Benzene exposure is generally accepted 
to cause acute myelogenous leukemia, but the association with 
multiple myeloma and non-Hodgkin’s lymphoma seems to be 
controversial [13]. The number of workers possibly exposed to 
benzene was estimated to be 196,182 in Korea [14]. It is report-
ed that Korean petrochemical workers can be exposed to high 
levels of benzene during turnaround maintenance [15].
Cohort studies on lymphohematopoietic cancers among 
workers exposed to benzene in the refinery/petrochemical in-
dustry have been conducted mainly in large enterprises. Some 
studies have presented significantly elevated risks of  lympho-
hematopoietic cancers. For example, Lewis et al. performed a 
follow-up study with employees working in oil refining compa-
nies from 1964 to 1994 and showed that the SMR of multiple 
myeloma alone increased to 1.94 (16/8.26; 95% CI: 1.11-3.15) 
among marketing and distribution workers [2]. However, many 
studies have shown insignificant or even decreased risks of lym-
phohematopoietic cancers. A follow-up study on the incidence 
of cancer in 5,614 workers of a petrochemical research facility 
in 1986-1997 conducted by Sathiakumar et al. found that the 
SIR of  non-Hodgkin’s lymphoma rose to 182 (95% CI: 94-
318) [3]. Rodu et al. showed that the SMRs of non-Hodgkin’s 
lymphoma and leukemias were 125 (95% CI: 51-259) and 38 
(95% CI: 5-136), respectively, by performing a follow-up study 
on 6,956 employees of a petrochemical research facility from 
1970 to 1996 [4]. Gamble et al. reported that the SMR of 
lymphohematopoietic cancers (113; 95% CI: 92-138) slightly 
increased in a study of  6,238 retired workers [16]. Tsai et al. 
performed a follow-up study with 4,639 active and former em-
ployees and retirees of Shell Oil Company from 1983 to 1999 
Table 4. Cancer morbidity results for all workers and by manufacture/office job
Kind of cancer
All workers (PY = 73747) Manufacturing (PY = 56510) Office (PY = 17237)
Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI
All cancer 144   1.12 0.95-1.32 108 1.19 0.98-1.44 36 0.97     0.68-1.34
Oral cavity, pharynx 4   1.19 0.32-3.05 4 1.67 0.45-4.27 0 -          0-3.12
Esophagus 1   0.49 0.01-2.71 0 -      0-2.19 1 1.46     0.04-8.14
Stomach 20   0.63 0.38-0.97 14 0.62 0.34-1.04 6 0.65     0.24-1.42
Colon, anus 11   0.69 0.34-1.24 8 0.71 0.31-1.40 3 0.64     0.13-1.87
Liver, biliary 22   0.82 0.52-1.25 17 0.90 0.52-1.43 5 0.65     0.21-1.51
Pancreas 2   0.69 0.08-2.50 1 0.49 0.01-2.75 1 1.15     0.03-6.42
Larynx 2   1.32 0.16-4.76 1 0.97 0.02-5.40 1 2.06     0.05-11.47
Lung 8 0.6 0.26-1.17 2 0.22 0.03-0.78 6 1.42     0.52-3.09
Skin 1   3.42   0.09-19.03 1 4.76   0.12-26.51 0 -          0-36.3
Prostate 3   1.86 0.38-5.43 3 2.80 0.58-8.19 0 -          0-5.50
Bladder 6   1.83 0.67-3.99 4 1.75 0.48-4.47 2 2.04     0.25-7.36
Neurologic 1   0.45 0.01-2.53 1 0.61 0.02-3.38 0 -          0-5.43
Lymphohematopoietic 6   0.81 0.30-1.77 5 0.92 0.30-2.14 1 0.52     0.01-2.89
Non-Hodgkins's lymphoma 3   0.77 0.16-2.25 2 0.70 0.08-2.52 1 0.97     0.02-5.39
Multiple myeloma 0 -      0-4.82 0 -      0-6.84 0 -          0-16.33
Leukemia 3   1.05 0.22-3.06 3 1.40 0.29-4.08 0 -          0-4.20
PY: person-year, Obs: observed number, SIR: standardized incidence ratio, CI: confidence interval.
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and showed that the SIRs of non-Hodgkin’s lymphoma (0.41; 
95% CI: 0.13-0.95) and leukemia (0.43; 95% CI: 0.09-1.25) 
were rather reduced and only the SIR of multiple myeloma was 
slightly increased at 1.23 (95% CI: 0.34-3.15) [7]. According to 
the results of  a follow-up study conducted by Tsai et al. with 
4,221 workers in the Louisiana oil refining and petrochemical 
industries, the SMR of overall lymphohematopoietic cancers 
(0.83; 95% CI: 0.47-1.38) was lower compared with the refer-
ence population, with concurrent lower SMRs for the workers 
employed for more than 10 years [6]. Through a follow-up 
study of 28,480 subjects from 1947 to 1993, the Texaco Mortal-
ity Study performed by Divine et al. reported that the SMRs of 
lymphohematopoietic cancers and leukemia were not higher 
in refinery/petrochemical workers compared with a reference 
population of 99 (95% CI: 87-113) and 101 (95% CI: 81-123), 
respectively [1]. Gun et al. also reported that the SIRs of  all 
leukemia and acute non-lymphocytic leukemia were not signifi-
cantly different from unity in an Australian petroleum industry 
cohort [17]. This inconsistency of results may be mainly due to 
sparse cases of lymphohematopoietic cancer and improvement 
of the work environment. Nonetheless, even low-level exposure 
to benzene at levels of < 1 ppm could decrease progenitor cells 
and affect the genetically susceptible subpopulation [18]. There-
fore, follow-up studies must continue despite the recent low 
level exposure in the work environment. 
Our study revealed significantly lower SMRs for all-
cause mortality and overall cancer mortality in refinery and 
petrochemical workers compared with the general population. 
These very low SMRs of all-cause mortality and overall cancer 
mortality represent a large healthy worker effect. However, the 
SMRs of leukemia and lymphohematopoietic cancers among 
the subjects were increased to 2.77 (95% CI: 0.75-7.09) and 
2 (95% CI: 0.65-4.66). Furthermore, the SIRs of  leukemias 
(2.24; 95% CI: 0.46-6.54) and lymphohematopoietic cancers 
(1.47; 95% CI: 0.48-3.44) among manufacturing workers also 
increased. SMRs and SIRs rose compared with the reference 
Table 5. Cancer morbidity results by four job classification
Kind of cancer
Product (PY = 35152)
Maintenance 
(PY = 12846)
Laboratory (PY = 8511) Office (PY = 17237)
Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI
All cancer 71 1.25    0.98-1.58 29 1.23   0.82-1.76 8 0.77  0.33-1.51 36 0.97    0.68-1.34
Oral cavity, pharynx 1 0.67    0.02-3.72 2 3.23   0.39-11.66 1 3.56  0.09-19.81 0 -    0-3.12
Esophagus 0 -    0-3.44 2 5.25   0.64-18.95 0 -  0-25.5 1 1.46    0.04-8.14
Stomach 8 0.57    0.24-1.12 5 0.84   0.27-1.97 1 0.39  0.01-2.17 6 0.65    0.24-1.42
Colon, anus 5 0.71    0.23-1.66 3 1.02   0.21-2.98 0 -  0-2.39 3 0.64    0.13-1.87
Liver, biliary 13 1.11    0.59-1.89 3 0.60   0.12-1.74 1 0.46  0.01-2.55 5 0.65    0.21-1.51
Pancreas 0 -    0-2.36 1 1.86   0.05-10.36 0 -  0-13.88 1 1.15    0.03-6.42
Larynx 0 -    0-4.60 1 3.56   0.09-19.84 0 -  0-30.21 1 2.06    0.05-11.47
Lung 2 0.34    0.04-1.23 0 -   0-1.21 0 -  0-3.41 6 1.42    0.52-3.09
Skin 0 -    0-22.96 0 -   0-54.44 1 40.54  1.03-225.86 0 -    0-36.3
Prostate 2 2.85    0.35-10.3 1 3.43   0.09-19.13 0 -  0-38.87 0 -    0-5.5
Bladder 4 2.77    0.76-7.10 0 -   0-4.97 0 -  0-12.24 2 2.04    0.25-7.36
Neurologic 0 -    0-2.92 0 -   0-7.63 1 4.32  0.11-24.09 0 -    0-5.43
Lymphohematopoietic 5 1.47    0.48-3.44 0 -   0-2.24 0 -  0-4.14 1 0.52    0.01-2.89
Non-Hodgkins's lymphoma 2 0.56    0.07-2.03 0 -   0-4.21 0 -  0-8.03 1 0.97    0.02-5.39
Multiple myeloma 0 -    0-10.92 0 -   0-26.11 0 -  0-61.27 0 -    0-16.33
Leukemia 3 2.24    0.46-6.54 0 -   0-5.89 0 -  0-9.95 0 -    0-4.20
PY: person-year, Obs: observed number, SIR: standardized incidence ratio, CI: confidence interval.
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population, but the differences were not statistically significant, 
because the statistical power was low due to the small number 
of lymphohematopoietic cancers and short follow-up duration. 
Compared with very low all-cause and overall cancer mortali-
ties, even non-significant elevations in mortalities might suggest 
an association between benzene exposure and lymphohemato-
poietic cancers. 
The latent period for lymphohematopoietic cancers is 
about 5 years, which is shorter than that for solid tumors, 
which have a latency of 10-20 years. However, the short latent 
period may be applicable when workers are exposed to high 
concentrations of carcinogens, such as benzene. If  workers are 
exposed to low concentrations, the latent period could be pro-
longed for much longer. In this regard, Aksoy, Vigliani, and Yin 
et al. reported average latent periods of  6-14, 3-23, and 11.4 
years for lymphohematopoietic cancers caused by benzene, 
respectively [19-21]. In our study, we could not apply a lag time 
because the follow-up period was short and the cases were 
scarce. However, follow-up studies are necessary in the future, 
as the current study may have underestimated the risk due to 
the short observation period and lack of exposure assessment.
In a follow-up study on cancer with 8,942 oil refining and 
petrochemical workers for 1983-1994, Huebner et al. divided 
subjects into processing operators, mechanical workers, techni-
cians, and office-based workers, and investigated the SIRs of 
lymphohematopoietic cancers [22]. We also divided subjects 
into two groups of  manufacturing and office workers, and 
four groups of production, maintenance, laboratory, and office 
workers, and calculated SMRs and SIRs for the lymphohema-
topoietic cancers. Merely dividing subjects by their job titles 
would have led to severe misclassification. Moreover, their 
assigned jobs were classified according to the last department 
they worked in. It would be preferable to classify individuals by 
their first job, because manufacturing workers with long job du-
rations can move to office jobs. However, we could not obtain 
enough data about employees’ first jobs, and this shortage of 
data may have caused a dilution effect by including unexposed 
subjects in the analysis of cohort [23]. 
In a study on the relationship between exposure to ben-
zene and leukemia with 74,828 workers exposed to benzene 
and 35,805 non-exposed workers in China conducted by Hayes 
et al., it was concluded that the risk of leukemia increased sig-
nificantly with cumulative doses of benzene over 40 ppm-years 
(for example, 1 ppm exposure for 40 years) [24]. The amount 
of  exposure could differ with employment time period, and 
generally the amount of  exposure is considered to have been 
higher in the past. Huebner et al. conducted a follow-up study 
with 7,637 and 7,007 workers of  the oil refining and petro-
chemical industries in Baton Rouge and Baytown, respectively, 
during 1970-1997 [5]. They showed that, after dividing work-
ers’ hire years into three groups; before 1940, 1940-1944, and 
1945-1949, the SMRs for total lymphohematopoietic cancers 
were higher in the earlier years of employment, at 1.87, 1.65, 
and 1.36, respectively. The SMRs for non-Hodgkin’s lym-
phoma were 2.11, 1.38, and 1.39, and those for leukemia were 
2.41, 1.96, and 1.33, respectively. Our cohort was young, so 
the exposure amount would be lower than those of the earlier 
studies, and this might have resulted in underestimation of the 
effect of benzene. 
A dose-response relationship should be considered to de-
termine the correlation between exposure to hazardous chemi-
cals and an outbreak of cancer. For this, it is ideal to evaluate 
the relationship by making a job-exposure matrix using the 
amount and duration of exposure. However, determining the 
amount and duration of exposure were impossible in our study, 
as it was performed with workers in seven factories and we 
could not obtain enough information about work environment 
exposure and old job history. A re-analysis after constructing a 
job-exposure matrix might lead to different results.
  The classification of outcome variables is very important 
in cohort studies. In particular, as the number of lymphohema-
topoietic cancers is very low, misclassification of  output can 
affect results to a large degree. We matched cohort subjects’ 
data with national death and cancer registries; however, the 
precision of the output is dependent on the completeness and 
accuracy of the registry. Incompleteness of registries might be a 
limitation to some degree.
Another limitation of our study is that we could not con-
trol for possible confounding variables acting on the relation-
ship between exposure and cancer, such as smoking, drinking, 
and socioeconomic status.
  In conclusion, the SMRs for leukemia (2.77; 95% CI: 
0.75-7.09) and lymphohematopoietic cancers (2; 95% CI: 0.65-
4.66), and the SIRs for leukemia (2.24; 95% CI: 0.46-6.54) and 
lymphohematopoietic cancers (1.47; 95% CI: 0.48-3.44) tended 
to be higher in production workers, but the results were not 
statistically significant. Although lymphohematopoietic cancers 
mortality did not increase significantly in this study, the overall 
mortality and overall cancer mortality were significantly lower 
in these subjects than in the general population. The results 
suggest a possible correlation between occupational exposure 
and lymphohematopoietic cancers. 
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